Categories AlphaGraphs, Earnings, Health Care
Infographic: Key highlights from Merck’s (MRK) Q2 2023 earnings results
Merck (NYSE: MRK) reported second quarter 2023 earnings results today.
Total worldwide sales were $15 billion, up 3% from the same period a year ago.
GAAP net loss was $5.9 billion, or $2.35 per share, compared to net income of $3.9 billion, or $1.55 per share, last year. Adjusted loss per share was $2.06.
For the full year of 2023, the company expects sales of $58.6-59.6 billion and adjusted EPS of $2.95-3.05.
Prior performance
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was